ArticleOncology reports2020

miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway.

Tonghai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.